- Shareholder Newsletter May 2016
- LBT Granted Patent in Japan for Core APAS Technology
Cochlear Executive Brent Barnes Appointed CEO of LBT Innovations
Senior Cochlear Limited executive Mr Brent Barnes has been appointed the new Chief Executive Officer of Adelaide-based technology developer LBT Innovations Limited (LBT).
Mr Barnes will begin his tenure on 8 August and will replace Mrs Lusia Guthrie, who has been CEO of LBT Innovations since she co-founded the company in 2004. Mrs Guthrie will assist with the transition.
- Appendix 4C
Company OverviewOver the past decade, LBT Innovations has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefi...
MicroStreakIn its first five years of global sales, LBT’s MicroStreak technology captured the largest share of the international market for automated culture-plate streaking and inoculation. Originally sold by bi...
APASThe Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...